Healthcare start-ups eye potential investors at Hong Kong’s global health summit
- About 180 local and overseas healthcare start-ups to showcase innovations at Asia Summit on Global Health
- Chief Executive John Lee and World Health Organization deputy director-general Zsuzsanna Jakab among speakers at summit
Local and overseas healthcare start-ups are eyeing potential investors at Hong Kong’s second Asia global health summit to implement their cutting-edge findings and bring fresh ideas to the sector.
The Asia Summit on Global Health, to be held from Thursday to Friday, will showcase innovations from about 180 healthcare start-ups, including Cognitact, led by a Hong Kong University of Science and Technology research team that developed a blood test to provide a diagnosis for Alzheimer’s disease before symptoms appear.
Joyce Ouyang Li, managing director of Cognitact, said: “Our research focuses on detecting biomarkers in blood that are associated with Alzheimer’s disease.”
“With early testing, patients can receive early disease management, which will be helpful in treating the disease … The disease leads to a heavy burden on family members and society, so early disease management is necessary.”
Li said she expected to recruit investors and business partners at the summit as the company was planning to introduce the blood test to the public in the second quarter of next year.
“We hope that more people will get to know our research findings, which can provide help to the ageing population, and promote our service,” she said.
The summit starting on Thursday marks the second edition of the event. It is among the highlights of the city’s first International Healthcare Week, organised by the Hong Kong Trade Development Council from November 1 to 15.
